Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Diabetes Mellitus, Insulin-Dependent, 12 2Uveal Melanoma 1Salivary Gland Neoplasms 1

Interventions

CTLA-4 Antigen 2envafolimab 1Radiosurgery 1Radiation 1Paclitaxel 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Diabetes Mellitus, Insulin-Dependent, 12 × CTLA-4 Antigen × Clear all
NCT03182816 2017-06-09

CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor

Shanghai Cell Therapy Research Institute

Phase 1/2 Unknown
40 enrolled

Diabetes Mellitus, Insulin-Dependent, 12

NCT03179007 2017-06-07

CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor

Shanghai Cell Therapy Research Institute

Phase 1/2 Unknown
40 enrolled

Diabetes Mellitus, Insulin-Dependent, 12

Data powered by HemOnc (CC BY 4.0) Colophon âš¡